1) long-acting injectable risperidone(RLAI)
长效利培酮微球
1.
Efficacy and safety of long-acting injectable risperidone(RLAI) in 40 patients with schizophrenia;
注射用长效利培酮微球治疗40例精神分裂症疗效与安全性研究
2) long-acting risperidone microsphere
长效利培酮微球注射剂
1.
Pharmacoeconomic evaluation of long-acting risperidone microsphere injection;
从药物经济学角度解析长效利培酮微球注射剂的临床应用
3) risperidone long-acting injection
注射用利培酮微球
1.
Methods:Patients were randomly divided into two groups,and treated with either risperidone long-acting injection(n=27) or haloperidol(n = 27 ).
目的:研究注射用利培酮微球对精神分裂症患者生活质量的改善作用。
5) risperidone
利培酮
1.
Study on sustained-release risperidone biodegradable microspheres;
利培酮生物可降解微球的研究
2.
Determination of Risperidone and 9-Hydroxyrisperidone in Plasma by High Performance Liquid Chromatography;
反相高效液相色谱法测定人血浆中利培酮及其代谢物的质量浓度
3.
Comparison study of Citalopram and Citalopram combined with Risperidone in treatment of somatoform disorders;
西酞普兰合并利培酮治疗躯体形式障碍的对照研究
6) Risperidon
利培酮
1.
Cost-effectiveness analysis of Risperidon and Clozapine in the treatment of schizophrenia;
利培酮、氯氮平治疗精神分裂症的成本-效果分析
2.
The therapeutic effectiveness and side reaction of Risperidon for chronic schizophrenia by dynamic observation;
利培酮对慢性精神分裂症疗效及副反应的动态观察
3.
Influence of risperidon on effects, memory and attention function in schizophrenia;
利培酮对精神分裂症的疗效及对记忆和注意功能的影响
补充资料：利培酮
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条